Canada Life’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.52M Sell
85,472
-3,323
-4% -$240K 0.01% 639
2025
Q4
$5.67M Buy
88,795
+61,384
+224% +$3.78M 0.01% 702
2025
Q3
$1.72M Buy
27,411
+10,666
+64% +$744K ﹤0.01% 1285
2025
Q2
$1.25M Sell
16,745
-29,463
-64% -$2.32M ﹤0.01% 1363
2025
Q1
$4.08M Sell
46,208
-208
-0.4% -$19.6K 0.01% 872
2024
Q4
$4.24M Sell
46,416
-9,698
-17% -$994K 0.01% 923
2024
Q3
$6.29M Buy
56,114
+4,362
+8% +$436K 0.01% 746
2024
Q2
$5.07M Buy
51,752
+10,756
+26% +$1.07M 0.01% 815
2024
Q1
$4.11M Buy
40,996
+457
+1% +$40.2K 0.01% 901
2023
Q4
$3.63M Sell
40,539
-20,878
-34% -$1.66M 0.01% 936
2023
Q3
$4.71M Buy
61,417
+68
+0.1% +$5.64K 0.01% 760
2023
Q2
$5.16M Sell
61,349
-3,543
-5% -$288K 0.01% 709
2023
Q1
$5.48M Buy
64,892
+253
+0.4% +$21.7K 0.01% 702
2022
Q4
$5.29M Sell
64,639
-4,025
-6% -$324K 0.01% 707
2022
Q3
$4.88M Sell
68,664
-4,229
-6% -$380K 0.01% 693
2022
Q2
$6.55M Sell
72,893
-7,349
-9% -$761K 0.02% 626
2022
Q1
$9.48M Sell
80,242
-4,239
-5% -$497K 0.02% 598
2021
Q4
$10.2M Sell
84,481
-119
-0.1% -$13.2K 0.02% 585
2021
Q3
$8.58M Buy
84,600
+288
+0.3% +$31.8K 0.02% 616
2021
Q2
$9.83M Sell
84,312
-1,484
-2% -$178K 0.02% 607
2021
Q1
$9.39M Sell
85,796
-192,485
-69% -$20.9M 0.02% 619
2020
Q4
$27.9M Sell
278,281
-21,408
-7% -$1.99M 0.05% 342
2020
Q3
$23.4M Sell
299,689
-3,138
-1% -$237K 0.05% 346
2020
Q2
$21M Buy
302,827
+156,010
+106% +$9.83M 0.05% 352
2020
Q1
$6.86M Buy
146,817
+510
+0.3% +$32.8K 0.02% 538
2019
Q4
$11.5M Buy
146,307
+48,929
+50% +$3.76M 0.03% 525
2019
Q3
$7.19M Buy
97,378
+886
+0.9% +$63.6K 0.02% 598
2019
Q2
$7.51M Sell
96,492
-139,365
-59% -$10.6M 0.02% 622
2019
Q1
$17.8M Sell
235,857
-53,644
-19% -$4.26M 0.05% 346
2018
Q4
$20.9M Sell
289,501
-5,135
-2% -$409K 0.06% 296
2018
Q3
$28.3M Sell
294,636
-16,880
-5% -$1.67M 0.07% 277
2018
Q2
$31.2M Sell
311,516
-7,814
-2% -$825K 0.07% 270
2018
Q1
$33.7M Sell
319,330
-28,590
-8% -$2.89M 0.08% 249
2017
Q4
$32.2M Buy
347,920
+234,774
+207% +$21.3M 0.08% 262
2017
Q3
$10.2M Buy
113,146
+5,437
+5% +$463K 0.03% 518
2017
Q2
$9.04M Sell
107,709
-5,999
-5% -$483K 0.02% 544
2017
Q1
$9.18M Sell
113,708
-832
-0.7% -$65.4K 0.02% 515
2016
Q4
$8.64M Sell
114,540
-203,468
-64% -$14.7M 0.02% 520
2016
Q3
$21.5M Sell
318,008
-706
-0.2% -$47.4K 0.06% 302
2016
Q2
$21.6M Buy
318,714
+31,506
+11% +$2.32M 0.06% 296
2016
Q1
$20.7M Sell
287,208
-23,184
-7% -$1.52M 0.08% 258
2015
Q4
$21M Sell
310,392
-1,992
-0.6% -$139K 0.08% 252
2015
Q3
$20.2M Buy
312,384
+20,030
+7% +$1.48M 0.08% 255
2015
Q2
$23.9M Sell
292,354
-2,460
-0.8% -$190K 0.08% 266
2015
Q1
$20.4M Buy
294,814
+25,022
+9% +$1.81M 0.07% 293
2014
Q4
$20.5M Buy
269,792
+1,049
+0.4% +$82.9K 0.07% 292
2014
Q3
$21.8M Buy
268,743
+453
+0.2% +$37.8K 0.07% 282
2014
Q2
$23.4M Buy
268,290
+20,024
+8% +$1.74M 0.08% 269
2014
Q1
$21.3M Buy
248,266
+1,622
+0.7% +$133K 0.07% 274
2013
Q4
$20M Buy
246,644
+177,239
+255% +$13.8M 0.07% 282
2013
Q3
$5.39M Buy
69,405
+68,776
+10,934% +$5.3M 0.02% 543
2013
Q2
$44K Buy
+629
New +$43.8K ﹤0.01% 701

Other funds holding EMN

Canada Life's EMN Position: Q1 2026 in Review

Canada Life reduced its Eastman Chemical (EMN) stake by 3.7% in Q1 2026, selling an estimated $240K and leaving 85,472 shares worth $6.52M. The position accounts for 0.01% of the portfolio, ranked #639.

Canada Life first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.7M in Q1 2018. 635 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Canada Life held 85,472 shares of Eastman Chemical worth $6.52M as of Q1 2026.
  • Canada Life sold 3,323 Eastman Chemical shares in Q1 2026, an estimated $240K.
  • Eastman Chemical made up 0.01% of Canada Life's portfolio in Q1 2026, its #639 holding.
  • Canada Life first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's Eastman Chemical position peaked at $33.7M in Q1 2018.
  • 635 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.